Astria Therapeutics, Inc. (ATXS)
Jan 26, 2026 - ATXS was delisted (reason: acquired by BCRX)
12.58
0.00 (0.00%)
Inactive · Last trade price on Jan 22, 2026

Astria Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
96.2859.82175.5320.5386.5124.93
Short-Term Investments
131.44268.3171205.913920
Cash & Short-Term Investments
227.72328.13246.53226.44125.5144.93
Cash Growth
-33.86%33.10%8.87%80.42%179.34%23.96%
Accounts Receivable
17.24-----
Other Current Assets
8.586.514.411.251.571.4
Total Current Assets
253.55334.64250.94227.69127.0846.33
Net Property, Plant & Equipment
4.255.110.360.950.390.97
Other Long-Term Assets
14.072.613.3620.050.17
Total Assets
271.87342.36254.67230.63127.5147.46
Accounts Payable
1.144.321.510.791.561.54
Accrued Expenses
16.4813.439.717.693.284.2
Current Portion of Leases
1.41.380.330.580.370.65
Unearned Revenue
4.5-----
Total Current Liabilities
23.5219.1311.559.065.26.39
Long-Term Leases
3.063.97-0.36-0.4
Other Long-Term Liabilities
12.04-----
Total Long-Term Liabilities
15.13.97-0.36-0.4
Total Liabilities
38.6123.111.559.425.26.79
Preferred Stock
95.3295.3295.3296.496.4-
Common Stock
0.060.060.040.030.010
Additional Paid-in Capital
911.01898.52728.29632.51481.71301.56
Accumulated Other Comprehensive Income
0.060.16--0.08--
Retained Earnings
-773.2-674.79-580.53-507.64-455.81-260.9
Shareholders' Equity
233.25319.26243.12221.22122.3140.67
Total Liabilities & Equity
271.87342.36254.67230.63127.5147.46
Total Debt
4.465.350.330.940.371.05
Net Cash (Debt)
223.27322.78246.2225.5125.1443.88
Net Cash Growth
-30.83%31.10%9.18%80.19%185.17%29.10%
Net Cash Per Share
3.855.758.1715.4214.0214.35
Book Value
233.25319.26243.12221.22122.3140.67
Book Value Per Share
4.025.688.0715.1313.7013.30
Tangible Book Value
233.25319.26243.12221.22122.3140.67
Tangible Book Value Per Share
4.025.688.0715.1313.7013.30
Updated Nov 12, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q